V
Vincent Lenaerts
Researcher at Université de Montréal
Publications - 38
Citations - 1136
Vincent Lenaerts is an academic researcher from Université de Montréal. The author has contributed to research in topics: Controlled release & Poloxamer. The author has an hindex of 20, co-authored 38 publications receiving 1109 citations.
Papers
More filters
Journal ArticleDOI
Cross-linked high amylose starch for controlled release of drugs: recent advances.
Vincent Lenaerts,Iskandar S. Moussa,Yves Dumoulin,F Mebsout,F Chouinard,Pompilia Ispas Szabo,Mircea-Alexandru Mateescu,Louis Cartilier,Robert H. Marchessault +8 more
TL;DR: It is hypothesized that the capacity of amylose to undergo the V to B transition is an important factor in controlling water transport and drug release rate and applications to different drugs are reviewed briefly.
Journal ArticleDOI
Temperature-dependent rheological behavior of pluronic F-127 aqueous solutions
Vincent Lenaerts,Caroline Triqueneaux,Michel Quartern,Françoise Rieg-Falson,Patrick Couvreur +4 more
TL;DR: In this article, a cross-linked network was proposed to explain the thermally induced swelling and desolvatation of pluronic micelles in aqueous solutions.
Journal ArticleDOI
Controlled release of theophylline from cross-linked amylose tablets
TL;DR: The analysis of the data indicates that an anomalous release mechanism controls the transport of the drug; this includes neither Fickian diffusion nor glassy/rubbery transition.
Journal ArticleDOI
Cross-linked high amylose starch derivatives as matrices for controlled release of high drug loadings.
TL;DR: These new polymeric excipients are able to control the release over 20 h from monolithic tablets loaded with 20 to 60% drug and represent a novel generation of pharmaceuticalexcipients recommended for high loading dosage formulations.
Journal ArticleDOI
Diffusion of rat atrial natriuretic factor in thermoreversible poloxamer gels.
TL;DR: Concentrated poloxamer 407 solutions display a negative thermorheological behaviour, resulting in a higher viscosity at body temperature than below, which could be exploited for various controlled delivery applications including the nasal delivery of peptides.